C. Larsson

C. Larsson, M. Bäckdahl, B. Hamberger, 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

The human NOTCH1, 2, and 3 genes are located at chromosome positions 9q34, 1p13-p11, and 19p13.2-p13.1 in regions of neoplasia-associated translocation.

C. Larsson, U. Lendahl, M. Lardelli, 1994, Genomics.

Novel and recurrent KIF21A mutations in congenital fibrosis of the extraocular muscles type 1 and 3.

C. Larsson, Kanxing Zhao, Chen Zhao, 2008, Archives of ophthalmology.

Malignant melanoma in patients with multiple endocrine neoplasia type 1 and involvement of the MEN1 gene in sporadic melanoma

C. Larsson, B. Teh, G. Robertson, 2000, International journal of cancer.

Germline and de novo mutations in the HRPT2 tumour suppressor gene in familial isolated hyperparathyroidism (FIHP)

J. Carpten, C. Larsson, B. Teh, 2004, Journal of Medical Genetics.

Absence of nucleolar parafibromin immunoreactivity in subsets of parathyroid malignant tumours

C. Larsson, A. Arnold, C. Juhlin, 2011, Virchows Archiv.

Heterogeneous expression of receptor mRNAs in parathyroid glands of secondary hyperparathyroidism.

C. Larsson, F. Farnebo, L. Farnebo, 2001, Kidney international.

Decreased expression of calcium-sensing receptor messenger ribonucleic acids in parathyroid adenomas.

C. Larsson, K. Sandelin, A. Höög, 1998, Surgery.

Molecular genetics of adrenal cortical tumors

C. Larsson, M. Bäckdahl, L. Roshani, 1999 .

Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors.

C. Larsson, K. Sandelin, B. Skogseid, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Localization of the genetic defect in multiple endocrine neoplasia type 1 within a small region of chromosome 11.

P. O'Connell, C. Larsson, Y. Nakamura, 1989, American journal of human genetics.

No overrepresentation of congenital adrenal hyperplasia in patients with adrenocortical tumours

C. Larsson, M. Bäckdahl, A. Wedell, 1999, Clinical endocrinology.

Gelatinase A and Membrane-type 1 Matrix Metalloproteinase mRNA: Expressed in Adrenocortical Cancers but Not in Adenomas

C. Larsson, M. Bäckdahl, Hiroshi Sato, 1999, World Journal of Surgery.

Human Anaplastic Thyroid Carcinoma Cells Are Sensitive to NK Cell–Mediated Lysis via ULBP2/5/6 and Chemoattract NK Cells

C. Larsson, J. Zedenius, A. Lundqvist, 2014, Clinical Cancer Research.

The Ras effectors NORE1A and RASSF1A are frequently inactivated in pheochromocytoma and abdominal paraganglioma.

O. Larsson, C. Larsson, M. Bäckdahl, 2007, Endocrine-related cancer.

Family Screening in Multiple Endocrine Type 1 (MEN 1) Neoplasia

C. Larsson, M. Nordenskjöld, 1994 .

Aberrations of centrosomes in adrenocortical tumors.

C. Larsson, G. Auer, K. Fujioka, 2002, International journal of oncology.

Gain of 17q in malignant fibrous histiocytoma is associated with a longer disease-free survival and a low risk of developing distant metastasis

O. Larsson, C. Larsson, W. Lui, 2003, British Journal of Cancer.

Differential Protein Expression Profiles of Cyst Fluid from Papillary Thyroid Carcinoma and Benign Thyroid Lesions

C. Larsson, J. Lehtiö, M. Pernemalm, 2015, PloS one.

Single-nuclei transcriptomes from human adrenal gland reveal distinct cellular identities of low and high-risk neuroblastoma tumors

C. Larsson, P. Kharchenko, Q. Deng, 2021, Nature Communications.

Single-nuclei transcriptomes from human adrenal gland reveal distinct cellular identities of low and high-risk neuroblastoma tumors

C. Larsson, P. Kharchenko, O. Bedoya-Reina, 2021, Nature Communications.

Inhibition of Parathyroid Hormone Secretion by Caffeine in Human Parathyroid Cells

C. Larsson, R. Bränström, L. Farnebo, 2013, The Journal of clinical endocrinology and metabolism.

MIB-1 index in thyroid tumors: a predictor of the clinical course in papillary thyroid carcinoma.

C. Larsson, G. Auer, J. Zedenius, 2003, Thyroid : official journal of the American Thyroid Association.

Acute myeloid leukemia - Apoptotic signalling and gene expression associated with treatment response

C. Larsson, B. Gjertsen, L. Kanter, 2013 .

Fine mapping of the locus for nevoid basal cell carcinoma syndrome on chromosome 9q.

C. Larsson, E. Holmberg, M. Ståhle-Bäckdahl, 1997, Acta dermato-venereologica.

Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria

G. Comi, C. Larsson, V. Tiranti, 2001, Nature Genetics.

REGULATION OF CELLULAR DEGRADATION PATHWAYS BY VIRAL ONCOPROTEINS AND MICRORNAS

C. Larsson, Akademisk Avhandling, S. Linder, 2020 .

Clinical and genetic studies of Van der Woude syndrome in Sweden.

C. Larsson, B. Teh, J. Huggare, 1999, Acta odontologica Scandinavica.

Loss of miR-514a-3p regulation of PEG3 activates the NF-kappa B pathway in human testicular germ cell tumors

C. Larsson, W. Lui, L. Ährlund‐Richter, 2017, Cell Death & Disease.

The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma

C. Larsson, M. Bäckdahl, W. Lui, 2011, Endocrine-related cancer.

The pattern of gene expression and gene dose profiles of 6-Mercaptopurine- and 6-Thioguanine-resistant human leukemia cells.

C. Larsson, J. Hashemi, A. Moshfegh, 2011, Biochemical and biophysical research communications.

Heterogeneity of Metabolic Vulnerability in Imatinib-Resistant Gastrointestinal Stromal Tumor

C. Larsson, W. Lui, C. Yeh, 2020, Cells.

MicroRNA expression profiles in non-epithelial ovarian tumors

Olga Hrydziuszko, C. Larsson, R. K. Chang, 2017, International journal of oncology.

Prognostic Impact of Immunohistochemical Expression of Ezrin in Highly Malignant Soft Tissue Sarcomas

Wen-Hui Weng, C. Larsson, W. Lui, 2005, Clinical Cancer Research.

GABPA-dependent down-regulation of DICER1 in follicular thyroid tumours

C. Larsson, W. Lui, A. Stenman, 2020, Endocrine-related cancer.

Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma.

O. Larsson, C. Larsson, L. Girnita, 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

Distinct deleted regions on chromosome segment 16q23–24 associated with metastases in prostate cancer

C. Larsson, G. Berx, F. van Roy, 1999, Genes, chromosomes & cancer.

Recurrent genomic alterations in benign and malignant pheochromocytomas and paragangliomas revealed by whole-genome array comparative genomic hybridization analysis.

C. Larsson, J. Komorowski, A. Piotrowski, 2010, Endocrine-related cancer.

High allele loss rates at I7q I2‐q2I in breast and ovarian tumors from BRCAI‐linked families

J. Chang-Claude, B. Ponder, C. Larsson, 1995 .

Autosomal-dominant retinitis pigmentosa caused by a mutation in SNRNP200, a gene required for unwinding of U4/U6 snRNAs.

C. Larsson, S. Daiger, S. Bowne, 2009, American journal of human genetics.

Mutation analysis of the BRCA2 gene in 49 site–specific breast cancer families

C. Larsson, J. Lancaster, P. Tonin, 1996, Nature Genetics.

Methylation of the p16INK4A promoter is associated with malignant behavior in abdominal extra-adrenal paragangliomas but not pheochromocytomas.

C. Larsson, M. Bäckdahl, T. Ekström, 2008, Endocrine-related cancer.

Differential loss of heterozygosity in the region of the Cowden locus within 10q22-23 in follicular thyroid adenomas and carcinomas.

C. Larsson, H. Kremer, C. Eng, 1997, Cancer research.

Chromosome localization, sequence analysis, and expression pattern identify FKHL 18 as a novel human forkhead gene.

C. Larsson, M. Hulander, P. Carlsson, 1997, Genomics.

Chromosomal localization of six human forkhead genes, freac-1 (FKHL5), -3 (FKHL7), -4 (FKHL8), -5 (FKHL9), -6 (FKHL10), and -8 (FKHL12).

C. Larsson, P. Carlsson, S. Enerbäck, 1995, Genomics.

Founder effect in multiple endocrine neoplasia type 1 (MEN 1) in Finland

C. Larsson, B. Teh, T. Ebeling, 2001, Journal of medical genetics.

Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism.

C. Larsson, N. Hayward, B. Teh, 1998, The Journal of clinical endocrinology and metabolism.

Rare germline mutations identified by targeted next-generation sequencing of susceptibility genes in pheochromocytoma and paraganglioma.

Jenny Welander, Adam Andreasson, C. Larsson, 2014, The Journal of clinical endocrinology and metabolism.

Selective loss of chromosome 11 in pheochromocytomas associated with the VHL syndrome

C. Larsson, B. Teh, S. Khoo, 2002, Oncogene.

miR-223-3p regulates cell growth and apoptosis via FBXW7 suggesting an oncogenic role in human testicular germ cell tumors

C. Larsson, W. Lui, Jikai Liu, 2016, International journal of oncology.

CREB3L2-PPARgamma fusion mutation identifies a thyroid signaling pathway regulated by intramembrane proteolysis.

E. Kaplan, C. Larsson, M. Tretiakova, 2008, Cancer research.

Signaling Pathway Regulated by Intramembrane Proteolysis Fusion Mutation Identifies a Thyroid γ CREB 3 L 2-PPAR Updated

E. Kaplan, C. Larsson, M. Tretiakova, 2008 .

Imatinib Regulates miR-483-3p and Mitochondrial Respiratory Complexes in Gastrointestinal Stromal Tumors

C. Larsson, W. Lui, K. Zeljic, 2021, International journal of molecular sciences.

5q11, 8p11, and 10q22 are recurrent chromosomal breakpoints in prostate cancer cell lines

C. Larsson, T. Visakorpi, J. Isola, 2001, Genes, chromosomes & cancer.

Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing.

S. Mane, C. Larsson, D. Rimm, 2015, Human molecular genetics.

The Ras effector NORE1A is suppressed in follicular thyroid carcinomas with a PAX8-PPARgamma fusion.

C. Larsson, Amy Y. M. Au, W. Lui, 2006, The Journal of clinical endocrinology and metabolism.

Chromosomal distribution, localization and expression of the human endogenous retrovirus ERV9

C. Larsson, A. Di Cristofano, G. La Mantia, 2001, Cytogenetic and Genome Research.

Silencing of the PTEN tumor‐suppressor gene in anaplastic thyroid cancer

Charis Eng, T. Dwight, C. Larsson, 2002, Genes, chromosomes & cancer.

On 13 q 14 deletions in chronic lymphocytic leukemia

C. Larsson, D. Grandér, D. Oscier, 2008 .

Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma

C. Larsson, B. Skogseid, M. Nordenskjöld, 1988, Nature.

Complete characterization of a large marker chromosome by reverse and forward chromosome painting

B. Ponder, C. Larsson, E. Blennow, 1992, Human Genetics.

Detailed characterization of a complex karyotype in a patient with primary plasma cell leukaemia using multicolour spectral karyotyping and micro-FISH.

C. Larsson, A. Nordgren, E. Blennow, 2000, The hematology journal : the official journal of the European Haematology Association.

Independent genetic events associated with the development of multiple parathyroid tumors in patients with primary hyperparathyroidism.

T. Dwight, C. Larsson, B. Teh, 2002, The American journal of pathology.

Loss of Heterozygosity on the Short Arm of Chromosome 1 in Pheochromocytoma and Abdominal Paraganglioma

C. Larsson, M. Bäckdahl, C. Juhlin, 2002, World Journal of Surgery.

Genetic analysis of lithium-associated parathyroid tumors.

T. Dwight, C. Larsson, B. Teh, 2002, European journal of endocrinology.

Loss of heterozygosity in sporadic parathyroid tumours: involvement of chromosome 1 and the MEN1 gene locus in 11q13.

T. Dwight, C. Larsson, B. Teh, 2000, Clinical endocrinology.

Comparative genomic hybridization reveals frequent losses of chromosomes 1p and 3q in pheochromocytomas and abdominal paragangliomas, suggesting a common genetic etiology.

C. Larsson, B. Teh, M. Bäckdahl, 2000, The American journal of pathology.

Loss of constitutional heterozygosity in human cancer: A practical approach

C. Larsson, J. Zedenius, G. Weber, 1995 .

Multiple endocrine neoplasia type I: clinical syndrome to molecular genetics.

C. Larsson, N. Hayward, B. Teh, 1995, The Australian and New Zealand journal of surgery.

Genetic and epigenetic background and protein expression profiles in relation to telomerase activation in medullary thyroid carcinoma

C. Larsson, M. Bäckdahl, J. Lehtiö, 2016, Oncotarget.

Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma.

Annabelle L. Fonseca, S. Mane, C. Larsson, 2015, The Journal of clinical endocrinology and metabolism.

Merkel cell polyomavirus T-antigens regulate DICER1 mRNA stability and translation through HSC70

C. Larsson, W. Lui, C. Juhlin, 2021, iScience.

Merkel cell polyomavirus oncoproteins induce microRNAs that suppress multiple autophagy genes

C. Larsson, W. Lui, Satendra Kumar, 2019, International journal of cancer.

GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression

C. Larsson, A. Stenman, Dawei Xu, 2018, Oncogene.

Clinical and functional impact of TARBP2 over-expression in adrenocortical carcinoma

C. Larsson, M. Bäckdahl, W. Lui, 2013, Endocrine-related cancer.

Quantitative global and gene-specific promoter methylation in relation to biological properties of neuroblastomas

C. Larsson, P. Kogner, J. Johnsen, 2012, BMC Medical Genetics.

Pheochromocytoma and functional paraganglioma syndrome: No longer the 10% tumor

C. Larsson, E. Elder, G. Elder, 2005, Journal of surgical oncology.

Frequent Promoter Hypermethylation of the APC and RASSF1A Tumour Suppressors in Parathyroid Tumours

C. Larsson, J. Nordenström, C. Juhlin, 2010, PloS one.

Candidate genes for multiple endocrine neoplasia type 1

C. Larsson, N. Hayward, S. Grimmond, 1995, Journal of internal medicine.

Characterization of large chromosome markers in a malignant fibrous histiocytoma by spectral karyotyping, comparative genomic hybridization (CGH), and array CGH.

C. Larsson, W. Lui, W. Weng, 2004, Cancer genetics and cytogenetics.

A highly aggressive primitive mesenchymal tumor with a translocation (1;19)(q12;q13.2).

C. Larsson, W. Lui, J. Wejde, 2001, Cancer genetics and cytogenetics.

The mouse homologs of RELA and MLK3 are located within a 120-kb fragment on Chromosome 19

C. Larsson, J. Guénet, N. Lassam, 1997, Mammalian Genome.

Gain of 1q and loss of 9q21.3‐q32 are associated with a less favorable prognosis in papillary thyroid carcinoma

C. Larsson, J. Zedenius, G. Wallin, 2001, Genes, chromosomes & cancer.

Transcriptional profiling enables molecular classification of adrenocortical tumours.

C. Larsson, P. Nilsson, J. Lundeberg, 2009, European journal of endocrinology.

The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas

C. Larsson, J. Zedenius, A. Dinets, 2014, Oncogene.

Aberrations of chromosome 8 in 16 breast cancer cell lines by comparative genomic hybridization, fluorescence in situ hybridization, and spectral karyotyping.

C. Larsson, J. Isola, J. Rummukainen, 2001, Cancer genetics and cytogenetics.

Molecular cytogenetic profiles of novel and established human anaplastic thyroid carcinoma models.

C. Larsson, W. Lui, J. Hashemi, 2007, Thyroid : official journal of the American Thyroid Association.

Structure and localization of the human insulin-like growth factor-binding protein 2 gene.

C. Larsson, H. Luthman, K. Brøndum‐Nielsen, 1991, Biochemical and biophysical research communications.

Localization of the human insulin-like growth-factor-binding protein 4 gene to chromosomal region 17q12–21.1

C. Larsson, H. Luthman, K. Brøndum‐Nielsen, 1992, Human Genetics.

Contiguous localization of the genes encoding human insulin-like growth factor binding proteins 1 (IGBP1) and 3 (IGBP3) on chromosome 7.

C. Larsson, H. Luthman, D. Powell, 1992, Genomics.

Characterization of chromosomal abnormalities in prostate cancer cell lines by spectral karyotyping

C. Larsson, T. Visakorpi, J. Isola, 2000, Cytogenetic and Genome Research.

Genomic alterations in human breast carcinomas

C. Larsson, L. Skoog, M. Nordenskjöld, 1990, Genes, chromosomes & cancer.

Multiple endocrine neoplasia type 1.

C. Larsson, M. Nordenskjöld, B. Tean Teh, 2000, Seminars in cancer biology.

Expression of the BCL6 gene in the pre- and postnatal mouse.

C. Larsson, F. Piehl, J. Lagercrantz, 1998, Biochemical and biophysical research communications.

Detailed assessment of chromosome 22 aberrations in sporadic pheochromocytoma using array‐CGH

C. Langford, C. Larsson, S. Gregory, 2006, International journal of cancer.

Role of microRNAs and microRNA machinery in the pathogenesis of diffuse large B-cell lymphoma

Deniz M. Ozata, C. Larsson, P. Georgii‐Hemming, 2013, Blood Cancer Journal.

Mutation analysis of MEN1, HRPT2, CASR, CDKN1B, and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition.

L. Aaltonen, C. Larsson, P. Vahteristo, 2009, Journal of endocrinological investigation.

Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma.

J. Carpten, C. Larsson, C. Robbins, 2003, The New England journal of medicine.

HRPT2, encoding parafibromin, is mutated in hyperparathyroidism–jaw tumor syndrome

J. Carpten, E. Gillanders, J. Trent, 2002, Nature Genetics.

Patterns of chromosomal imbalances in parathyroid carcinomas.

C. Larsson, J. Isola, K. Sandelin, 2000, The American journal of pathology.

Alternative genetic pathways in parathyroid tumorigenesis.

T. Dwight, C. Larsson, B. Teh, 1999, The Journal of clinical endocrinology and metabolism.

Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors.

C. Larsson, C. Eng, R. Parsons, 1997, Cancer research.

Identification of two distinct deleted regions on chromosome 13 in prostate cancer

C. Larsson, J. Lancaster, A. Futreal, 1998, Oncogene.

LUMA (LUminometric Methylation Assay)--a high throughput method to the analysis of genomic DNA methylation.

Frank Lyko, Dan Grandér, Mohsen Karimi, 2006, Experimental cell research.

Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTC:s.

C. Larsson, M. Nordenskjöld, B. Hamberger, 1994, Human molecular genetics.

Involvement of the PAX8/peroxisome proliferator-activated receptor gamma rearrangement in follicular thyroid tumors.

T. Dwight, C. Larsson, W. Lui, 2003, The Journal of clinical endocrinology and metabolism.

Characterization of the mouse Men1 gene and its expression during development

C. Larsson, N. Hayward, B. Teh, 1998, Oncogene.

Chromosomal aberrations in benign and malignant Bilharzia-associated bladder lesions analyzed by comparative genomic hybridization

C. Larsson, N. Mandahl, M. Ibrahim, 2002, BMC Cancer.

Expression profiling reveals a distinct transcription signature in follicular thyroid carcinomas with a PAX8-PPARγ fusion oncogene

T. Dwight, C. Larsson, W. Lui, 2005, Oncogene.

Molecular Markers for Discrimination of Benign and Malignant Follicular Thyroid Tumors

Hanna Göransson, Mårten Fryknäs, Anders Isaksson, 2006, Tumor Biology.

Gene-specific promoter hypermethylation without global hypomethylation in follicular thyroid cancer.

C. Larsson, T. Foukakis, J. Zedenius, 2008, International journal of oncology.

Comparative genomic hybridization identifies loss of 18q22-qter as an early and specific event in tumorigenesis of midgut carcinoids.

C. Larsson, B. Cedermark, A. Höög, 2001, The American journal of pathology.

Comparative genomic hybridization reveals population-based genetic alterations in hepatoblastomas

C. Larsson, T. Ekström, S. Gray, 2000, British Journal of Cancer.

Tumor suppressor activity of the gene encoding mammary-derived growth inhibitor.

C. Larsson, H. Huynh, S. Narod, 1995, Cancer research.

Molecular profiles of oxyphilic and chief cell parathyroid adenoma

C. Larsson, J. Lehtiö, A. Höög, 2017, Molecular and Cellular Endocrinology.

Loss of parafibromin expression in a subset of parathyroid adenomas.

C. Larsson, B. Leibiger, I. Leibiger, 2006, Endocrine-related cancer.

Cytogenetic and expression profiles associated with transformation to androgen‐resistant prostate cancer

C. Larsson, W. Weng, S. Pang, 2006, The Prostate.

Loss of 14q31-q32.2 in renal cell carcinoma is associated with high malignancy grade and poor survival.

C. Larsson, U. Bergerheim, B. Sundelin, 2004, International journal of oncology.

Follicular thyroid tumors: clinical and genetic aspects

C. Larsson, J. Zedenius, G. Wallin, 2002 .

Loss of expression for the Wnt pathway components adenomatous polyposis coli and glycogen synthase kinase 3-beta in parathyroid carcinomas.

C. Larsson, K. Sandelin, A. Höög, 2009, International journal of oncology.

Methylation changes in the human IGF2 p3 promoter parallel IGF2 expression in the primary tumor, established cell line, and xenograft of a human hepatoblastoma.

C. Larsson, T. Ekström, D. V. von Schweinitz, 2001, Experimental cell research.

Molecular Genetics of Familial Hyperparathyroidism

C. Larsson, B. Teh, A. Höög, 2001 .

Spontaneously immortalized human T lymphocytes develop gain of chromosomal region 2p13–24 as an early and common genetic event

C. Larsson, E. Blennow, K. Chrzanowska, 2004, Genes, chromosomes & cancer.

Chromosomal alterations in 15 breast cancer cell lines by comparative genomic hybridization and spectral karyotyping

C. Larsson, J. Isola, A. Nordgren, 2000, Genes, chromosomes & cancer.

Proteomics Suggests a Role for APC-Survivin in Response to Somatostatin Analog Treatment of Neuroendocrine Tumors

C. Larsson, J. Lehtiö, J. Hashemi, 2016, The Journal of clinical endocrinology and metabolism.

Digital droplet PCR TERT promoter mutational screening in fine needle aspiration cytology of thyroid lesions: A highly specific technique for pre‐operative identification of high‐risk cases

C. Larsson, A. Stenman, K. Jatta, 2023, Diagnostic cytopathology.

Localization and identification of the multiple endocrine neoplasia type 1 disease gene.

C. Larsson, E. Friedman, Catharina Larsson, 1994, Endocrinology and metabolism clinics of North America.

Intracellular concentration of the tyrosine kinase inhibitor imatinib in gastrointestinal stromal tumor cells

C. Larsson, J. Bergquist, W. Lui, 2014, Anti-cancer drugs.

Characterisation of the human APC1, the largest subunit of the anaphase-promoting complex.

C. Larsson, S. Gräslund, R. Betz, 2001, Gene.

A comparative study of the expression patterns for vegf, vegf-b/vrf and vegf-c in the developing and adult mouse.

C. Larsson, F. Piehl, J. Lagercrantz, 1998, Biochimica et biophysica acta.

Detailed physical map of human chromosomal region 11q12-13 shows high meiotic recombination rate around the MEN1 locus.

C. Larsson, Y. Nakamura, B. Werelius, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Loss of ZDHHC15 expression in a woman with a balanced translocation t(X;15)(q13.3;cen) and severe mental retardation

Peter Gustavsson, C. Larsson, N. Dahl, 2005, European Journal of Human Genetics.

Distinction in gene expression profiles demonstrated in parathyroid adenomas by high-density oligoarray technology.

C. Larsson, J. Hashemi, M. Reimers, 2005, European journal of endocrinology.

Involvement of the MEN1 gene locus in familial isolated hyperparathyroidism.

T. Dwight, C. Larsson, B. Teh, 2002, European journal of endocrinology.

Parathyroid tumorigenesis in association with primary hyperparathyroidism

T. Dwight, C. Larsson, B. Teh, 2002 .

Homozygous inactivation of the MEN1 gene as a specific somatic event in a case of secondary hyperparathyroidism.

C. Larsson, S. Lagercrantz, F. Farnebo, 2001, European journal of endocrinology.

A family with isolated hyperparathyroidism segregating a missense MEN1 mutation and showing loss of the wild-type alleles in the parathyroid tumors.

C. Larsson, C. J. Pearce, B. Teh, 1998, American journal of human genetics.

Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Familial Isolated Hyperparathyroidism Maps to the Hyperparathyroidism-Jaw Tumor Locus in 1q21-q32 in a Subset of Families*

C. Larsson, B. Teh, K. Sandelin, 2022 .

MicroRNA Expression Patterns Related to Merkel Cell Polyomavirus Infection in Human Merkel Cell Carcinoma

C. Larsson, W. Lui, S. Caramuta, 2013, The Journal of investigative dermatology.

MiR-375 Regulation of LDHB Plays Distinct Roles in Polyomavirus-Positive and -Negative Merkel Cell Carcinoma

C. Larsson, W. Lui, Patrick Scicluna, 2018, Cancers.

Familial isolated hyperparathyroidism as a variant of multiple endocrine neoplasia type 1 in a large Danish pedigree.

C. Larsson, B. Teh, T. Kruse, 2000, The Journal of clinical endocrinology and metabolism.

Phenotype and phenocopy: the relationship between genotype and clinical phenotype in a single large family with multiple endocrine neoplasia type 1 (MEN 1)

C. Larsson, B. Teh, J. Burgess, 2000, Clinical endocrinology.

Adrenal lesion in multiple endocrine neoplasia type 1.

J. Rastad, C. Larsson, G. Åkerström, 1995, Surgery.

miR‐125a‐5p regulation increases phosphorylation of FAK that contributes to imatinib resistance in gastrointestinal stromal tumors

C. Larsson, W. Lui, E. Berglund, 2018, Experimental cell research.

Genomic organization and complete cDNA sequence of the human phosphoinositide-specific phospholipase C beta 3 gene (PLCB3).

C. Larsson, N. Hayward, S. Grimmond, 1995, Genomics.

Proteomic Profiling of Diffuse Large B-Cell Lymphomas

A. Kwiecińska, C. Larsson, S. Souchelnytskyi, 2018, Pathobiology.

Restriction map of a YAC and cosmid contig encompassing the oculopharyngeal muscular dystrophy candidate region on chromosome 14q11.2-q13.

C. Larsson, B. Brais, G. Rouleau, 1998, Genomics.

Evidence of a functional estrogen receptor in parathyroid adenomas.

Inga-Lena Nilsson, Johan Hartman, J. Hartman, 2012, The Journal of clinical endocrinology and metabolism.

Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas

C. Larsson, T. Ried, L. Morrison, 2006, British Journal of Cancer.

Association of a novel constitutional translocation t(1q;3q) with familial renal cell carcinoma

C. Larsson, B. Teh, D. Kedra, 2001, Journal of medical genetics.

microRNA expression signatures of gastrointestinal stromal tumours: associations with imatinib resistance and patient outcome

C. Larsson, W. Lui, E. Berglund, 2014, British Journal of Cancer.

TERT promoter hypermethylation is associated with poor prognosis in adrenocortical carcinoma.

C. Larsson, M. Bäckdahl, A. Stenman, 2018, International Journal of Molecular Medicine.

Genetics of Multiple Endocrine Neoplasia Type 1 a

C. Larsson, B. Teh, G. Weber, 1994, Annals of the New York Academy of Sciences.

Homozygotes for the autosomal dominant neoplasia syndrome (MEN1).

C. Larsson, M. Brandi, R. Castello, 1993, American journal of human genetics.

Sublocalization of the multiple endocrine neoplasia type 1 gene.

C. Larsson, G. Weber, M. Janson, 1992, Henry Ford Hospital medical journal.

Practical guidelines for DNA-based testing in multiple endocrine neoplasia type 1.

C. Larsson, B. Skogseid, K. Oberg, 1992, Henry Ford Hospital medical journal.

Genetic and clinical characteristics of multiple endocrine neoplasia type 1.

C. Larsson, B. Skogseid, K. Oberg, 1991, Acta oncologica.

Predictive testing for multiple endocrine neoplasia type 1 using DNA polymorphisms.

C. Larsson, Y. Nakamura, N. Hayward, 1992, The Journal of clinical investigation.

Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10

C. James, C. Larsson, W. Cavenee, 1993, Human Genetics.

Global hypomethylation and promoter methylation in small intestinal neuroendocrine tumors

C. Larsson, J. Hashemi, J. Zedenius, 2014, Epigenetics.

Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization

C. Larsson, J. Hashemi, J. Zedenius, 2013, BMC Cancer.

Molecular Characterization of Acquired Tolerance of Tumor Cells to Picropodophyllin (PPP)

O. Larsson, C. Larsson, W. Lui, 2011, PloS one.

A 10-year-old girl with bifocal synovial sarcoma.

O. Larsson, C. Larsson, J. Hashemi, 2006, The Lancet Oncology.

Downregulation and Hypermethylation of GABPB1 Is Associated with Aggressive Thyroid Cancer Features

C. Larsson, Shi-Yong Neo, Dawei Xu, 2022, Cancers.

PLEKHS1 Over-Expression is Associated with Metastases and Poor Outcomes in Papillary Thyroid Carcinoma

C. Larsson, Dawei Xu, Xiaotian Yuan, 2020, Cancers.

Telomerase reverse transcriptase promoter hypermethylation is associated with metastatic disease in abdominal paraganglioma

C. Larsson, A. Stenman, J. Zedenius, 2018, Clinical endocrinology.

TERT Promoter Hypermethylation in Gastrointestinal Cancer: A Potential Stool Biomarker.

C. Larsson, Dawei Xu, Li Liu, 2017, The oncologist.

Allelic loss on chromosome 11 is uncommon in parathyroid glands of patients with hypercalcaemic secondary hyperparathyroidism.

C. Larsson, J. Nordenström, F. Farnebo, 1997, The European journal of surgery = Acta chirurgica.

Frequent EPAS1 / HIF2 a exons 9 and 12 mutations in non-familial pheochromocytoma

C. Larsson, M. Bäckdahl, P. Söderkvist, 2014 .

TERT Promoter Mutation Spatial Heterogeneity in a Metastatic Follicular Thyroid Carcinoma: Implications for Clinical Work-Up

C. Larsson, A. Stenman, K. Jatta, 2019, Endocrine Pathology.

A PCR-based expression signature of malignancy in follicular thyroid tumors.

C. Larsson, Amy Y. M. Au, A. Gusnanto, 2007, Endocrine-related cancer.

Genetic background of adrenocortical tumor development

C. Larsson, M. Bäckdahl, M. Kjellman, 2001, World journal of surgery.

Calmodulin and calmodulin-dependent protein kinase II inhibit hormone secretion in human parathyroid adenoma.

C. Larsson, E. Berglund, A. Höög, 2011, The Journal of endocrinology.

Expression and association of TRPC subtypes with Orai1 and STIM1 in human parathyroid.

C. Larsson, E. Berglund, G. Westin, 2010, Journal of molecular endocrinology.

Molecular Profiling of Pheochromocytoma and Abdominal Paraganglioma Stratified by the PASS Algorithm Reveals Chromogranin B as Associated With Histologic Prediction of Malignant Behavior

C. Larsson, P. Söderkvist, A. Stenman, 2019, The American journal of surgical pathology.

Global and Regional CpG Methylation in Pheochromocytomas and Abdominal Paragangliomas: Association to Malignant Behavior

C. Larsson, M. Bäckdahl, T. Ekström, 2008, Clinical Cancer Research.

Multiple endocrine neoplasia type 1 (MEN1) in two Asian families

C. Larsson, N. Hayward, B. Teh, 1994, Human Genetics.

Balanced translocation (3;7)(p25;q34): another mechanism of tumorigenesis in follicular thyroid carcinoma?

C. Larsson, W. Lui, L. Farnebo, 2000, Cancer genetics and cytogenetics.

Low frequency of numerical chromosomal aberrations in follicular thyroid tumors detected by comparative genomic hybridization

C. Larsson, J. Zedenius, G. Wallin, 1999, Genes, chromosomes & cancer.

Global and Regional CpGMethylation in Pheochromocytomas and Abdominal Paragangliomas : Association toMalignant Behavior

C. Larsson, M. Karimi, J. Geli, 2008 .

Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria

G. Comi, C. Larsson, V. Tiranti, 2001, Nature Genetics.

Diagnostic and prognostic potential of MIB-1 proliferation index in thyroid fine needle aspiration biopsy.

C. Larsson, L. Skoog, T. Foukakis, 2009, International journal of oncology.

MicroRNA expression patterns associated with hyperfunctioning and non-hyperfunctioning phenotypes in adrenocortical adenomas.

C. Larsson, M. Bäckdahl, W. Lui, 2014, European journal of endocrinology.

Mapping of the second locus for the Van der Woude syndrome to chromosome 1p34

J. Kere, C. Larsson, B. Teh, 2001, European Journal of Human Genetics.

Genetic heterogeneity and exclusion of a modifying locus at 17p11.2-p11.1 in Finnish families with van der Woude syndrome

J. Kere, C. Larsson, B. Teh, 2001, Journal of medical genetics.

Role of SDHAF2 and SDHD in von Hippel–Lindau Associated Pheochromocytomas

C. Larsson, M. Bäckdahl, A. Fassina, 2014, World Journal of Surgery.

Epigenetic regulation of glucose transporter 4 by estrogen receptor β.

C. Larsson, T. Ekström, Wen Cai, 2011, Molecular endocrinology.

Sporadic primary hyperparathyroidism in the setting of multiple endocrine neoplasia type 1.

C. Larsson, B. Teh, J. McArdle, 1996, Archives of surgery.

Assignment of the human FAU gene to a subregion of chromosome 11q13.

C. Larsson, W. V. D. Van de Ven, E. Schoenmakers, 1993, Genomics.

Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1.

J. Rastad, C. Larsson, E. Wilander, 1992, The Journal of clinical endocrinology and metabolism.

Multiple endocrine neoplasia.

C. Larsson, M. Nordenskjöld, 1990, Cancer surveys.

Detailed assessment of copy number alterations revealing homozygous deletions in 1p and 13q in mantle cell lymphoma.

C. Larsson, R. Rosenquist, K. Ichimura, 2007, Leukemia research.

Amplification of 2p as a Genomic Marker for Transformation in Lymphoma

A. Kwiecińska, C. Larsson, K. Ichimura, 2014, Genes, chromosomes & cancer.

Genotyping of adrenocortical tumors: very frequent deletions of the MEN1 locus in 11q13 and of a 1-centimorgan region in 2p16.

C. Larsson, B. Teh, O. Kallioniemi, 1999, The Journal of clinical endocrinology and metabolism.

Parafibromin and APC as Screening Markers for Malignant Potential in Atypical Parathyroid Adenomas

C. Larsson, C. Juhlin, A. Höög, 2010, Endocrine pathology.

A rapid method for DNA extraction from fine-needle aspiration biopsies of thyroid tumors, and subsequent RET mutation analysis.

T. Dwight, C. Larsson, M. Bäckdahl, 1998, Cancer detection and prevention.

Pre-fractionation of archival frozen tumours for proteomics applications.

C. Larsson, R. Lewensohn, J. Lehtiö, 2006, Journal of biotechnology.

Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidism

C. Larsson, B. Teh, K. Sandelin, 1997, Human Genetics.

TOP2A Expression in Pheochromocytoma and Abdominal Paraganglioma: a Marker of Poor Clinical Outcome?

C. Larsson, A. Stenman, C. Juhlin, 2023, Endocrine Pathology.

Exclusion of FAU as the multiple endocrine neoplasia type 1 (MEN1) gene.

C. Larsson, E. Friedman, K. Sandelin, 1993, Human molecular genetics.

Proteomic profiling of follicular and papillary thyroid tumors

C. Larsson, U. Hellman, G. Auer, 2011, European journal of endocrinology.

Family screening in multiple endocrine neoplasia type 1 (MEN 1).

C. Larsson, M. Nordenskjöld, 1994, Annals of medicine.

The human mammary-derived growth inhibitor (MDGI) gene: genomic structure and mutation analysis in human breast tumors.

P. A. Futreal, C. Larsson, P. Tonin, 1996, Genomics.

TERT promoter mutations are rare in parathyroid tumors.

C. Larsson, M. Prasad, A. Stenman, 2015, Endocrine-related cancer.

Hyperparathyroidism of multiple endocrine neoplasia type 1: candidate gene and parathyroid calcium sensing protein expression.

J. Rastad, C. Larsson, G. Åkerström, 1995, Surgery.

Molecular cloning, characterization, and chromosomal localization of a human lymphoid tyrosine kinase related to murine Blk.

C. I. Smith, C. Larsson, K. Islam, 1995, Journal of immunology.

Genetic aberrations in adrenocortical tumors detected using comparative genomic hybridization correlate with tumor size and malignancy.

C. Larsson, O. Kallioniemi, M. Bäckdahl, 1996, Cancer research.

miR-205 Expression Promotes Cell Proliferation and Migration of Human Cervical Cancer Cells

C. Larsson, W. Lui, S. Caramuta, 2012, PloS one.

A novel locus (RP33) for autosomal dominant retinitis pigmentosa mapping to chromosomal region 2cen-q12.1

C. Larsson, Kanxing Zhao, Chen Zhao, 2006, Human Genetics.

Familial testicular cancer: lack of evidence for trinucleotide repeat expansions and association with PKD1 in one family

M. Stratton, C. Larsson, R. Huddart, 1999, Journal of medical genetics.

Sporadic follicular thyroid tumors show loss of a 200‐kb region in 11q13 without evidence for mutations in the MEN1 gene

C. Larsson, B. Teh, J. Zedenius, 1999, Genes, chromosomes & cancer.

Rearrangement of proximal 11q13 band in a CMML in acute transformation.

C. Larsson, J. Grosgeorge, N. Ayraud, 1995, Leukemia.

Molecular characterization of a recurring complex chromosomal translocation in two human extragonadal germ cell tumors.

A. Tanigami, C. Larsson, Y. Nakamura, 1994, Cancer genetics and cytogenetics.

Bilateral multiple renal oncocytomas and cysts associated with a constitutional translocation (8;9)(q24.1;q34.3) and a rare constitutional VHL missense substitution

C. Larsson, B. Teh, D. Nicol, 1998, Genes, chromosomes & cancer.

Genome-Wide and Locus Specific Alterations in CDC73/HRPT2-Mutated Parathyroid Tumors

C. Larsson, J. Nordenström, C. Juhlin, 2012, PloS one.

Lack of S37A CTNNB1/β‐catenin mutations in a Swedish cohort of 98 parathyroid adenomas

C. Larsson, A. Höög, C. Juhlin, 2010, Clinical endocrinology.

Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification.

C. Larsson, K. Sandelin, J. Nordenström, 2007, Endocrine-related cancer.

Distinct target regions for chromosome 1p deletions in parathyroid adenomas and carcinomas.

C. Larsson, L. Farnebo, S. Välimäki, 2002, International journal of oncology.

Linkage analysis of candidate regions in Swedish nonsyndromic cleft lip with or without cleft palate families.

C. Larsson, B. Teh, J. Huggare, 2000, The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association.

Targeted disruption of the mouse phospholipase C β3 gene results in early embryonic lethality

C. Larsson, C. Betsholtz, B. Skogseid, 1998, FEBS letters.

Exclusion of the phosphoinositide-specific phospholipase Cβ3 (PLCB3) gene as a candidate for multiple endocrine neoplasia type 1

C. Larsson, N. Hayward, S. Grimmond, 1996, Human Genetics.

Novel splicing of an IGF2 polymorphic region in human adrenocortical carcinomas.

C. Larsson, T. Ekström, S. Gray, 1997, Biochemical and biophysical research communications.

High Extracellular Ca2+ Hyperpolarizes Human Parathyroid Cells via Ca2+-activated K+ Channels*

C. Larsson, A. Höög, R. Bränström, 2003, Journal of Biological Chemistry.

Morphology, DNA ploidy and allele losses on chromosome 11 in sporadic hyperparathyroidism and that associated with multiple neoplasia, type 1.

C. Larsson, K. Sandelin, M. Nordenskjöld, 1992, The European journal of surgery = Acta chirurgica.

Characterization of the chromosomal gene and promoter for human insulin-like growth factor binding protein-5.

C. Larsson, H. Luthman, D. Powell, 1994, The Journal of biological chemistry.

Multiple endocrine neoplasia type 1 and the search for the genetic trigger.

C. Larsson, B. Teh, O. Nilsson, 1997, Hormone research.

Chromosomal Imbalances in Diffuse Large B-Cell Lymphoma Detected by Comparative Genomic Hybridization

Göran Roos, Svetlana Lagercrantz, Richard Rosenquist, 2002, Modern Pathology.

Minimally invasive follicular thyroid carcinomas: prognostic factors

C. Larsson, J. Zedenius, C. Lundgren, 2016, Endocrine.

Suppression of RIZ in biologically unfavourable neuroblastomas.

C. Larsson, P. Kogner, J. Geli, 2010, International journal of oncology.

DLEU2 encodes an antisense RNA for the putative bicistronic RFP2/LEU5 gene in humans and mouse

C. Larsson, D. Grandér, D. Oscier, 2004, Genes, chromosomes & cancer.

Two Chinese families with pulverulent congenital cataracts and deltaG91 CRYBA1 mutations.

J. Kere, C. Larsson, Kanxing Zhao, 2007, Molecular vision.

Detection of genomic amplification of the human telomerase gene TERC, a potential marker for triage of women with HPV-positive, abnormal Pap smears.

C. Larsson, T. Ried, K. Heselmeyer-Haddad, 2009, The American journal of pathology.

Wide Surgical Margin Improves the Outcome for Patients with Gastrointestinal Stromal Tumors (GISTs)

C. Larsson, J. Wejde, I. Nilsson, 2018, World Journal of Surgery.

Biochemical Inhibition of DOG1/TMEM16A Achieves Antitumoral Effects in Human Gastrointestinal Stromal Tumor Cells In Vitro

C. Larsson, E. Berglund, I. Nilsson, 2019, AntiCancer Research.

Secretome protein signature of human gastrointestinal stromal tumor cells.

C. Larsson, W. Lui, Jaeyoon Kim, 2015, Experimental cell research.

Novel functions and targets of miR-944 in human cervical cancer cells

R. Sandberg, C. Larsson, W. Lui, 2014, International journal of cancer.

Loss of chromosome 13q is a frequently acquired event in genetic progression of soft tissue sarcomas in the abdominal cavity.

C. Larsson, D. Grandér, W. Lui, 2005, International journal of oncology.

Mantle cell lymphomas with clonal immunoglobulin VH3–21 gene rearrangements exhibit fewer genomic imbalances than mantle cell lymphomas utilizing other immunoglobulin VH genes

C. Larsson, E. Thelander, R. Rosenquist, 2005, Modern Pathology.

Molecular characterization of parathyroid tumors from two patients with hereditary colorectal cancer syndromes

C. Larsson, F. Ferreira, A. Höög, 2012, Familial Cancer.

Expression analysis of RET and the GDNF/GFRalpha-1 and NTN/GFRalpha-2 ligand complexes in pheochromocytomas and paragangliomas.

C. Larsson, M. Bäckdahl, A. Höög, 2000, International journal of molecular medicine.

Direct interaction of the ATP-sensitive K+ channel by the tyrosine kinase inhibitors imatinib, sunitinib and nilotinib.

C. Larsson, W. Lui, E. Berglund, 2021, Biochemical and biophysical research communications.

Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy

C. Larsson, M. Jeddi-Tehrani, F. Shokri, 2008, International journal of cancer.

Human histone deacetylase 2, HDAC2 (Human RPD3), is localized to 6q21 by radiation hybrid mapping.

C. Larsson, T. Ekström, R. Betz, 1998, Genomics.

Identification of twelve new RFLP-markers on chromosome 22q11-qter

C. Larsson, P. Scambler, J. Dumanski, 1991, Human Genetics.

Evaluation of microRNA-205 expression as a potential triage marker for patients with low-grade squamous intraepithelial lesions

C. Larsson, W. Lui, A. Hjerpe, 2017, Oncology letters.

Predisposition for breast cancer in carriers of constitutional translocation 11q;22q.

C. Larsson, A. Lindblom, J. Dumanski, 1994, American journal of human genetics.

Linkage disequilibrium studies in multiple endocrine neoplasia type 1 (MEN1)

M. McCarthy, C. Larsson, B. Teh, 1997, Human Genetics.

Fine mapping of Best's macular dystrophy localizes the gene in close proximity to but distinct from the D11S480/ROM1 loci.

J. Weissenbach, C. Larsson, C. Graff, 1994, Genomics.

Mutation analysis of the BRG1 gene in prostate cancer clinical samples.

C. Larsson, Chunde Li, P. Ekman, 2003, International journal of oncology.

CGH alterations in medullary thyroid carcinomas in relation to the RET M918T mutation and clinical outcome.

C. Larsson, J. Zedenius, G. Wallin, 2001, International journal of oncology.

Gene identification in autosomal dominant disorders.

C. Larsson, B. Teh, J. Lagercrantz, 1997, AJNR. American journal of neuroradiology.

MUTATIONSOFCODON 918 INTHE RET PROTO-ONCOGENECORRELATE TOPOORPROGNOSISINSPORADIcMEDULLARYTHYROIDCARCINOMAS

C. Larsson, L. Grimelius, J. Zedenius, 1995 .

Definition of the minimal MEN1 candidate area based on a 5-Mb integrated map of proximal 11q13. The European Consortium on Men1, (GENEM 1; Groupe d'Etude des Néoplasies Endocriniennes Multiples de type 1).

C. Larsson, B. Teh, S. Forbes, 1996, Genomics.

Linkage Analysis of Candidate Regions in Swedish Nonsyndromic Cleft Lip with or without Cleft Palate Families

C. Larsson, B. Teh, J. Huggare, 2000 .

Characterization of chromosomal abnormalities in uroepithelial carcinomas by G‐banding, spectral karyotyping and FISH analysis

C. Larsson, U. Bergerheim, W. Lui, 2001, International journal of cancer.

Molecular characterization of parathyroid tumors from two patients with hereditary colorectal cancer syndromes

C. Larsson, S. Vale, F. Ferreira, 2012, Familial Cancer.

Evaluation of spectral karyotyping (SKY) in biodosimetry for the triage situation following gamma irradiation

C. Larsson, R. Lewensohn, S. Lagercrantz, 2006, International journal of radiation biology.

A novel FOXO1-mediated dedifferentiation blocking role for DKK3 in adrenocortical carcinogenesis

C. Larsson, U. Scholl, W. Knoefel, 2017, BMC Cancer.

Identification of numerical and structural chromosome aberrations in 15 high hyperdiploid childhood acute lymphoblastic leukemias using spectral karyotyping

C. Larsson, B. Johansson, A. Nordgren, 2001, European journal of haematology.

Aberrant splicing in neuroblastoma generates RNA-fusion transcripts and provides vulnerability to spliceosome inhibitors

C. Larsson, M. O'sullivan, O. Bedoya-Reina, 2021, Nucleic acids research.

Mapping of the human Ca2+ channel β4 subunit to 2q22-23 and its expression in developing mouse

C. Larsson, F. Piehl, R. Betz, 1998, Mammalian Genome.

Enhanced effects by 4-phenylbutyrate in combination with RTK inhibitors on proliferation in brain tumor cell models.

C. Larsson, T. Ekström, Ninib Baryawno, 2011, Biochemical and biophysical research communications.

Two Chinese families with pulverulent congenital cataracts and ∆ G 91 CRYBA 1 mutations

J. Kere, C. Larsson, Kanxing Zhao, 2007 .

Functional role of the Ca²⁺-activated Cl⁻ channel DOG1/TMEM16A in gastrointestinal stromal tumor cells.

C. Larsson, W. Lui, E. Berglund, 2014, Experimental cell research.

Isolation and characterization of a novel gene close to the human phosphoinositide-specific phospholipase C beta 3 gene on chromosomal region 11q13.

C. Larsson, M. Nordenskjöld, J. Lagercrantz, 1996, Genomics.

LRIG1 negatively regulates RET mutants and is downregulated in thyroid cancer

C. Larsson, T. Tot, R. Henriksson, 2018, International journal of oncology.

Thyroglobulin expression, Ki-67 index, and lymph node ratio in the prognostic assessment of papillary thyroid cancer

C. Larsson, J. Zedenius, I. Shabo, 2023, Scientific Reports.

Molecular cytogenetic characterization of four commonly used cell lines derived from Hodgkin lymphoma.

C. Larsson, W. Lui, G. Enblad, 2003, Cancer genetics and cytogenetics.

Alternative splicing in neuroblastoma generates RNA-fusion transcripts and is associated with vulnerability to spliceosome inhibitors

C. Larsson, M. O'sullivan, O. Bedoya-Reina, 2019 .

Molecular cytogenetic characterization shows higher genetic homogeneity in conventional renal cell carcinoma compared to other kidney cancers.

A. Zetterberg, C. Larsson, U. Bergerheim, 2004, International journal of oncology.

Evidence for Ca(2+)-regulated ATP release in gastrointestinal stromal tumors.

C. Larsson, M. Köhler, W. Lui, 2013, Experimental cell research.

Functional characterization of novel germline TP53 variants in Swedish families

C. Larsson, Å. Borg, K. Wiman, 2019, Clinical genetics.

Molecular cytogenetic characterization of primary cultures and established cell lines from non-medullary thyroid tumors.

T. Dwight, C. Larsson, W. Lui, 2005, International journal of oncology.

Normal structural dopamine type 2 receptor gene in prolactin-secreting and other pituitary tumors.

C. Larsson, R. Fahlbusch, E. Friedman, 1994, The Journal of clinical endocrinology and metabolism.

Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1.

C. Larsson, N. Hayward, B. Teh, 1997, Human molecular genetics.

Thymic carcinoids in multiple endocrine neoplasia type 1.

C. Larsson, B. Teh, B. Skogseid, 1998, Journal of internal medicine.

Clonal development of a blastoid mantle cell lymphoma studied with comparative genomic hybridization.

C. Larsson, R. Rosenquist, M. Erlanson, 2002, Cancer genetics and cytogenetics.

LETTERS TO THE EDITOR Epidermal mosaicism and Blaschko's lines Homozygosity at the dopamine D3 receptor locus is not associated with schizophrenia

Stephen, C. Larsson, M. Nordenskjold, 2004 .

Association between Predicted Effects of TP53 Missense Variants on Protein Conformation and Their Phenotypic Presentation as Li-Fraumeni Syndrome or Hereditary Breast Cancer

C. Larsson, R. Konrat, P. Kharaziha, 2021, International journal of molecular sciences.

paraganglioma: relation to adverse tumor phenotype and predisposing mutation

C. Larsson, C. Juhlin, O. Nilsson, 2013 .

Expression of genes involved with cell cycle control, cell growth and chromatin modification are altered in hepatoblastomas.

C. Larsson, W. Hartmann, D. V. von Schweinitz, 2000, International journal of molecular medicine.

Genetic aspects of multiple endocrine neoplasia types 1 and 2.

R. A. Decker, C. Larsson, K. Sandelin, 1994, Current opinion in general surgery.

Proteomic study of thyroid tumors reveals frequent up-regulation of the Ca2+ -binding protein S100A6 in papillary thyroid carcinoma.

C. Larsson, R. Branca, J. Lehtiö, 2010, Thyroid.

Global and Regional CpG Methylation in Pheochromocytomas and Abdominal Paragangliomas: Association to Malignant Behavior

C. Larsson, T. Ekström, M. Karimi, 2008, Clinical Cancer Research.

Comparative genomic hybridization reveals population-based genetic alterations in hepatoblastomas

C. Larsson, T. Matsunaga, S. Kytola, 2000, British Journal of Cancer.

Expression of the phosphoinositide‐specific phospholipase Cβ3 gene in the rat

C. Larsson, F. Piehl, M. Nordenskjöld, 1995, Neuroreport.

Enhanced effects by 4-phenylbutyrate in combination with RTK inhibitors on proliferation in brain tumor cell models.

C. Larsson, T. Ekström, Ninib Baryawno, 2011, Biochemical and biophysical research communications.

Identifying cancer-related genes in nasopharyngeal carcinoma cell lines using DNA and mRNA expression profiling analyses.

Bin Tean Teh, Brian Haab, C. Larsson, 2002, International journal of oncology.

New chromosomal breakpoints in non-Hodgkin's lymphomas revealed by spectral karyotyping and G-banding.

C. Larsson, A. Nordgren, E. Blennow, 2000, International journal of molecular medicine.